Spots Global Cancer Trial Database for chronic myelocytic leukemia
Every month we try and update this database with for chronic myelocytic leukemia cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Evaluating True PCR-negative Rate of Frontline Dasatinib in Early Chronic Phase CML for Therapeutic Harmonization | NCT02975115 | Chronic Myelocy... | RQ-PCR RNA Anal... | 18 Years - | Seoul St. Mary's Hospital | |
| TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation | NCT01300611 | Double Cord Blo... Acute Myelogeno... Myelodysplastic... Myelofibrosis Acute Lymphobla... Chronic Myelocy... Non Hodgkins Ly... Hodgkins Lympho... Chronic Lymphoc... | TXA127 300 mcg/... TXA127 1000 mcg... | 18 Years - 60 Years | Tarix Pharmaceuticals | |
| Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS) | NCT00854646 | Acute Myelocyti... Acute Lymphocyt... Chronic Myelocy... Chronic Lymphoc... Myelodysplastic... | ON 01910.Na | 18 Years - | Traws Pharma, Inc. | |
| Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion | NCT00966810 | Philadelphia Ch... | Stem cell trans... | 18 Years - 65 Years | Rambam Health Care Campus | |
| Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS) | NCT00854646 | Acute Myelocyti... Acute Lymphocyt... Chronic Myelocy... Chronic Lymphoc... Myelodysplastic... | ON 01910.Na | 18 Years - | Traws Pharma, Inc. | |
| Rasburicase in Patients at Risk for Tumor Lysis Syndrome | NCT00628628 | Tumor Lysis Syn... | As Needed Rasbu... Fixed Dose Rasb... | - | M.D. Anderson Cancer Center | |
| Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer | NCT01607892 | Hematological M... | KPT-330 | 18 Years - | Karyopharm Therapeutics Inc | |
| TXA127 in Enhancement of Engraftment in Adult Double Cord Blood Transplantation | NCT01300611 | Double Cord Blo... Acute Myelogeno... Myelodysplastic... Myelofibrosis Acute Lymphobla... Chronic Myelocy... Non Hodgkins Ly... Hodgkins Lympho... Chronic Lymphoc... | TXA127 300 mcg/... TXA127 1000 mcg... | 18 Years - 60 Years | Tarix Pharmaceuticals | |
| Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer | NCT01607892 | Hematological M... | KPT-330 | 18 Years - | Karyopharm Therapeutics Inc | |
| Allogeneic Stem Cell Transplantation in CML With Partial T Cell Depletion | NCT00966810 | Philadelphia Ch... | Stem cell trans... | 18 Years - 65 Years | Rambam Health Care Campus | |
| Phase I Study of ON 01910.Na in Refractory Leukemia or Myelodysplastic Syndrome (MDS) | NCT00854646 | Acute Myelocyti... Acute Lymphocyt... Chronic Myelocy... Chronic Lymphoc... Myelodysplastic... | ON 01910.Na | 18 Years - | Traws Pharma, Inc. | |
| T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant | NCT01621477 | Acute Lymphobla... Acute Myelocyti... Chronic Myelocy... Juvenile Myelom... Myelodysplastic... Hodgkin or Non-... Sarcoma, Myeloi... | clofarabine cytarabine busulfan Plerixafor cyclophosphamid... antithymocyte g... stem cells Tacrolimus mycophenolate m... | - 21 Years | St. Jude Children's Research Hospital | |
| Methotrexate or Pentostatin for Graft-versus-host Disease Prophylaxis in Risk-adapted Allogeneic Bone Marrow Transplantation for Hematologic Malignancies | NCT01188798 | Acute Lymphobla... Acute Myelocyti... Chronic Myelocy... Hodgkin's Disea... Myelodysplastic... | Methotrexate Pentostatin | 18 Months - 21 Years | St. Jude Children's Research Hospital | |
| Assess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients | NCT04150471 | Chronic Myelocy... | RQ-PCR(Real-tim... | 18 Years - | Seoul St. Mary's Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
